MA28527B1 - Formulations orales contenant licarbazepine - Google Patents

Formulations orales contenant licarbazepine

Info

Publication number
MA28527B1
MA28527B1 MA29380A MA29380A MA28527B1 MA 28527 B1 MA28527 B1 MA 28527B1 MA 29380 A MA29380 A MA 29380A MA 29380 A MA29380 A MA 29380A MA 28527 B1 MA28527 B1 MA 28527B1
Authority
MA
Morocco
Prior art keywords
formulations containing
oral formulations
licarbazepine
containing licarbazepine
oral
Prior art date
Application number
MA29380A
Other languages
English (en)
French (fr)
Inventor
Oskar Kalb
Marie-Christine Wolf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0406379A external-priority patent/GB0406379D0/en
Priority claimed from GB0406738A external-priority patent/GB0406738D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA28527B1 publication Critical patent/MA28527B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
MA29380A 2004-03-22 2006-10-11 Formulations orales contenant licarbazepine MA28527B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0406379A GB0406379D0 (en) 2004-03-22 2004-03-22 Organic compounds
GB0406738A GB0406738D0 (en) 2004-03-25 2004-03-25 Organic compounds

Publications (1)

Publication Number Publication Date
MA28527B1 true MA28527B1 (fr) 2007-04-03

Family

ID=34961345

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29380A MA28527B1 (fr) 2004-03-22 2006-10-11 Formulations orales contenant licarbazepine

Country Status (16)

Country Link
US (1) US20070196488A1 (2)
EP (1) EP1732519A1 (2)
JP (1) JP2007529564A (2)
AR (1) AR048318A1 (2)
AU (1) AU2005226910B2 (2)
BR (1) BRPI0509067A (2)
CA (1) CA2558787A1 (2)
EC (1) ECSP066860A (2)
IL (1) IL177826A0 (2)
MA (1) MA28527B1 (2)
MX (1) MXPA06010810A (2)
NO (1) NO20064808L (2)
PE (1) PE20051156A1 (2)
RU (1) RU2006137330A (2)
TW (1) TW200534844A (2)
WO (1) WO2005092294A1 (2)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
EP2380575B1 (en) * 2005-05-06 2015-02-25 Bial-Portela & CA, S.A. Eslicarbazepine acetate and use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
WO2012120356A2 (en) 2011-03-08 2012-09-13 Jubilant Life Sciences Limited Process for the preparation of (s)-(+)-or (r)-(-)-10 hydroxy dihydrodibenz[b,f]azepines by enantioselective reduction of 10, 11-dihydro-10-oxo-5h-dibenz[b,f]azepines and polymorphs thereof
EP2498481A1 (en) 2011-03-09 2012-09-12 Sensirion AG Mobile phone with humidity sensor
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
PT3402488T (pt) 2015-12-18 2022-01-25 Jubilant Generics Ltd Formas de dosagem orais sólidas de eslicarbazepina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
IL125244A (en) * 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
AU2003240654A1 (en) * 2002-05-31 2003-12-19 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
JP2005538126A (ja) * 2002-08-06 2005-12-15 ノバルティス アクチエンゲゼルシャフト 耳鳴の処置のためのカルボキサミドの使用
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina

Also Published As

Publication number Publication date
TW200534844A (en) 2005-11-01
NO20064808L (no) 2006-12-15
AU2005226910B2 (en) 2009-06-04
RU2006137330A (ru) 2008-05-10
JP2007529564A (ja) 2007-10-25
IL177826A0 (en) 2006-12-31
WO2005092294A1 (en) 2005-10-06
EP1732519A1 (en) 2006-12-20
AU2005226910A1 (en) 2005-10-06
ECSP066860A (es) 2006-11-24
MXPA06010810A (es) 2006-12-15
CA2558787A1 (en) 2005-10-06
BRPI0509067A (pt) 2007-08-21
AR048318A1 (es) 2006-04-19
US20070196488A1 (en) 2007-08-23
PE20051156A1 (es) 2006-02-13

Similar Documents

Publication Publication Date Title
TWI368491B (en) Oral care toothbrush
PH12006502549B1 (en) Oral care film
TWI365064B (en) Oral care implement
TWI369974B (en) Oral care implement
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
EP1506786A4 (en) MEDICAL GHRELIN CONTAINING COMPOSITIONS
IS8460A (is) Lyfjafræðileg samsetning sem inniheldur kvetíapín
DK1765303T3 (da) Misbrugsikret, oral dispenseringsform
BRPI0511900A (pt) composições farmacêuticas
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DK1587478T3 (da) Farmaceutisk sammensætning
SK4325U (sk) Farmaceutická kompozícia s postupným uvoľňovaním
DK1755540T3 (da) Mundplejesammensætninger
ATE551051T1 (de) Orales arzneimittelabgabesystem
MA28527B1 (fr) Formulations orales contenant licarbazepine
DK1985303T3 (da) Oral sammensætning indeholdende interferon-alpha
EP1941896A4 (en) DIPEPTIDE-CONTAINING COMPOSITION FOR ORAL ADMINISTRATION
GB0514943D0 (en) Oral care compositions
ITMI20042232A1 (it) Composizione farmaceutica contenente clozapina
DK1948126T3 (da) Oral sammensætning indeholdende morin
IS7290A (is) Lyfjasamsetningar sem innihalda risperidone
PL377147A1 (pl) Doustna kompozycja
DK1684688T3 (da) Pilledispenser
NO20042027L (no) Oral composition
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante